Ovia Fertility

Disease Category:
Target Audience:

Clinical Effectiveness
Version: 3.7.8
Developer: Ovuline
Review Date: 2016-04-17
Cost: Free

Overall App Summary:

The Ovia Fertility app is well designed and can be a great tool for women of child-bearing age interested in conceiving. It is quite helpful for monitoring peak fertility window, get reminders of such windows, and even get a daily fertility score. The app encourages recording of various related factors such as activity, mood, vital signs, etc. and integrates with various wellness devices. However, despite being a great app, there is no evidence of its effectiveness. There are anecdotal reports in media and claims from company executives, but there are no publications in peer-reviewed journals establishing the effectiveness of this product. Overall the app may be a useful tool for those seeking to chart and record their fertility but relying on insights from the app may be risky and it would be best to consult with a healthcare provider and review data collected by the app together as a team.


App’s Intended Use:

The Ovia Fertility app is intended to be used by women of child-bearing age for fertility planning. It claims to help women conceive faster by tracking menstrual cycle, ovulation, and related symptoms.


Who’s this app most useful for?

Women of child-bearing age who are trying to conceive.


How should they use it?

For optimal benefit, women who are interested in using the app, should, on a monthly basis, enter their start of menses and days of sexual intercourse. If they happen to own an ovulation predictor kit, they should also enter that information into the app. The more information you enter (for example, body temperature, symptoms, pelvic pain), the app uses all the information to provide peak fertility windows, usually a span of 3-5 days.


Why should anyone use this app? Is the mobile app clinically relevant?

The Ovia Fertility app is a convenient way to track the fertility window and may help replace paper/pencil charting of fertility. For many women, it is very difficult to keep track of all the relevant factors that affect fertility, and the Ovia Fertility mobile app really simplifies fertility tracking. Perhaps most importantly, it notifies you “when” you woman should engage in sexual intercourse, somewhere in the fertility window, so that you have the best chance for getting pregnant. However, it is difficult to evaluate the insights the app offers to claim and there does not seem to be strong evidence that it can actually help someone conceive more quickly. The reviewer is unaware of any publication that provides evidence that the Ovia Fertility app actually increases conception rate.

Is there any published evidence that the app actually works?

The company executives claim that the Ovia Fertility App can get users pregnant up to 3 times faster than the national average. However, the reviewers are unaware of any publication in peer-reviewed academic journals. The only “evidence” is anecdotal stories and public statements from company employees.


Regulatory Compliance

Not FDA cleared, but will most likely be exempt under MMA guidance – enforcement discretion.


What is the most important/ desirable feature of the app?

The app has a number of great features that are quite useful for women interested in tracking their menstrual cycle and identifying the optimal fertility window. Perhaps the most important are the timely reminders and notifications.  The ability to integrate with fitness trackers also seems useful.


How is the usability of the app?

The app is easy to learn to use. It has a nice look and feel, is easy to navigate and is quite intuitive. However, some sections of the app seem cluttered and overwhelming (too much information).

Maulik Majmudar

Dr. Maulik Majmudar is a practicing cardiologist and Associate Director of the Healthcare Transformation Lab at Massachusetts General Hospital; and an Instructor at Harvard Medical School. He lectures at Massachusetts Institute of Technology in areas of healthcare innovation & entrepreneurship, as well as medical device design and development. Dr. Majmudar started his career as a medical student at Northwestern University Feinberg School of Medicine, completed resident training in Internal Medicine at The Johns Hopkins Hospital, and followed by a fellowship in Cardiovascular Medicine at Brigham and Women's Hospital at Harvard Medical School. You can follow him @mmajmudar

Conflicts of Interest:

Employment: Massachusetts General Hospital and Harvard Medical School; Consultant/ Advisor: AliveCor, BioFourmis, Cardiogram, EchoSense, Facebook, HUINNO, MC10, Nokia; Ownership: BioFourmis, Cardiogram, HiLabs, Quanttus; Research: EchoSense, GE Healthcare, MIT.

John Torous

Dr. John Torous is a clinical fellow and senior resident in psychiatry at Brigham and Women’s Hospital in Boston, Massachusetts who has a background in electrical engineering and computer sciences. He is chair of the American Psychiatric Association’s work group on smartphone apps and has also developed his own smartphone apps for clinical psychiatric research. He has published numerous papers on smartphone apps and app evaluation, and his work has been featured in Scientific American and Nature News. He is editor in chief of JMIR Mental Health, the leading journal for mental health and technology, and co-chair the Massachusetts Psychiatric Society's health information technology committee.

Adam Landman

Dr. Adam Landman, is an emergency physician and Chief Medical Information Officer at the Brigham and Women’s Hospital (BWH). Dr. Landman holds degrees in information systems and health care policy from Carnegie Mellon University and a medical degree from UMDNJ – Robert Wood Johnson Medical School. After medical school, he trained in emergency medicine at the University of California, Los Angeles, and completed the RWJ Foundation Clinical Scholars fellowship in health services research, where he worked on qualitative and quantitative studies on the adoption of health information technology (HIT) in the emergency department (ED) and prehospital settings.

Conflicts of Interest:

Employment: Brigham and Women's Hospital and Harvard Medical School; Consultant/ Advisor: None; Ownership: None; Research: CRICO.

Leave a Reply

Your email address will not be published. Required fields are marked *